Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Multiple Sclerosis

  Free Subscription


Articles published in J Neurol Sci

Retrieve available abstracts of 61 articles:
HTML format



Single Articles


    November 2021
  1. KENNEY R, Liu M, Patil S, Alroughani R, et al
    Long-term outcomes in patients presenting with optic neuritis: Analyses of the MSBase registry.
    J Neurol Sci. 2021;430:118067.
    PubMed     Abstract available


    October 2021
  2. BEARD K, Sriwastava S
    Insight in booster COVID-19 vaccine and disease modifying therapy in multiple sclerosis.
    J Neurol Sci. 2021;430:120034.
    PubMed    


  3. BRINGELAND GH, Blaser N, Myhr KM, Vedeler CA, et al
    Wearing-off symptoms during standard and extended natalizumab dosing intervals: Experiences from the COVID-19 pandemic.
    J Neurol Sci. 2021;429:117622.
    PubMed     Abstract available


  4. SCOTT TF
    Neurosarcoidosis mimicry of MS: Clues from cases with CNS tissue diagnosis.
    J Neurol Sci. 2021;429:117621.
    PubMed     Abstract available


    September 2021
  5. PLOWMAN RS, Varma H
    Prognostic factors in Tumefactive demyelinating lesions: A retrospective study.
    J Neurol Sci. 2021;428:117591.
    PubMed     Abstract available


  6. XIE JS, Jeeva-Patel T, Margolin E
    Balo's concentric sclerosis - A rare entity within the spectrum of demyelinating diseases.
    J Neurol Sci. 2021;428:117570.
    PubMed     Abstract available


  7. CRISTIANO E, Abad P, Becker J, Carra A, et al
    Multiple sclerosis care units in Latin America: Consensus recommendations about its objectives and functioning implementation.
    J Neurol Sci. 2021;429:118072.
    PubMed     Abstract available


    August 2021
  8. RICE DR, Kaplan TB, Hotan GC, Vogel AC, et al
    Electronic pill bottles to monitor and promote medication adherence for people with multiple sclerosis: A randomized, virtual clinical trial.
    J Neurol Sci. 2021;428:117612.
    PubMed     Abstract available


    July 2021
  9. VISSER LA, Huls SPI, Uyl-de Groot CA, de Bekker-Grob EW, et al
    An implantable device to treat multiple sclerosis: A discrete choice experiment on patient preferences in three European countries.
    J Neurol Sci. 2021;428:117587.
    PubMed     Abstract available


    June 2021
  10. VAN DER HIELE K, van Gorp DAM, van Egmond EEA, Jongen PJ, et al
    Self-reported occupational functioning in persons with relapsing-remitting multiple sclerosis: Does personality matter?
    J Neurol Sci. 2021;427:117561.
    PubMed     Abstract available


  11. JAKIMOVSKI D, Zivadinov R, Vaughn CB, Ozel O, et al
    Clinical effects associated with five-year retinal nerve fiber layer thinning in multiple sclerosis.
    J Neurol Sci. 2021;427:117552.
    PubMed     Abstract available


  12. WIJERATNE T, Grisold W, Carroll W
    World Brain Day 2021 campaign continue to gain the momentum; join us to stop multiple sclerosis.
    J Neurol Sci. 2021;427:117547.
    PubMed    


  13. FUJIMORI J, Nakashima I
    Serum neurofilament light is a sensitive biomarker that reflects grey matter volume in Japanese patients with multiple sclerosis.
    J Neurol Sci. 2021;427:117528.
    PubMed     Abstract available


    May 2021
  14. TAZZA F, Lapucci C, Cellerino M, Boffa G, et al
    Personalizing ocrelizumab treatment in Multiple Sclerosis: What can we learn from Sars-Cov2 pandemic?
    J Neurol Sci. 2021;427:117501.
    PubMed     Abstract available


  15. DE MERCANTI SF, Signori A, Cordioli C, Signoriello E, et al
    MRI activity and extended interval of Natalizumab dosing regimen: a multicentre Italian study.
    J Neurol Sci. 2021;424:117385.
    PubMed     Abstract available


    April 2021
  16. YOUNG CA, Mills R, Rog D, Sharrack B, et al
    Quality of life in multiple sclerosis is dominated by fatigue, disability and self-efficacy.
    J Neurol Sci. 2021;426:117437.
    PubMed     Abstract available


  17. ALLUM JHJ, Rust HM, Lutz N, Schouenborg C, et al
    Characteristics of improvements in balance control using vibro-tactile biofeedback of trunk sway for multiple sclerosis patients.
    J Neurol Sci. 2021;425:117432.
    PubMed     Abstract available


    March 2021
  18. FERRARO D, Annovazzi P, Lanzillo R, Calabrese M, et al
    A multicenter survey on access to care in Multiple Sclerosis-related trigeminal neuralgia.
    J Neurol Sci. 2021;424:117430.
    PubMed     Abstract available


    February 2021
  19. EILAM-STOCK T, Shaw MT, Krupp LB, Charvet LE, et al
    Early neuropsychological markers of cognitive involvement in multiple sclerosis.
    J Neurol Sci. 2021;423:117349.
    PubMed     Abstract available


    January 2021
  20. BOSE G, Freedman MS
    Recent advances and remaining questions of autologous hematopoietic stem cell transplantation in multiple sclerosis.
    J Neurol Sci. 2021;421:117324.
    PubMed     Abstract available


  21. KOVVURU S, Nalleballe K, Onteddu SR, Sharma R, et al
    Immunosuppression in chronic autoimmune neurological disorders during the COVID-19 pandemic.
    J Neurol Sci. 2021;420:117230.
    PubMed     Abstract available


    December 2020
  22. WEBER J, Bernsdorff N, Robinson T, Endres D, et al
    Diagnosis of multiple sclerosis in times of MOG and AQP4 autoantibody testing - A monocentric study.
    J Neurol Sci. 2020;421:117289.
    PubMed     Abstract available


    October 2020
  23. VARMA-DOYLE AV, Lukiw WJ, Zhao Y, Lovera J, et al
    A hypothesis-generating scoping review of miRs identified in both multiple sclerosis and dementia, their protein targets, and miR signaling pathways.
    J Neurol Sci. 2020 Oct 23:117202. doi: 10.1016/j.jns.2020.117202.
    PubMed     Abstract available


  24. BARREIRO-GONZALEZ A, Sanz MT, Carratala-Bosca S, Perez-Miralles F, et al
    Magnetic resonance imaging and optical coherence tomography correlations in multiple sclerosis beyond anatomical landmarks.
    J Neurol Sci. 2020;419:117180.
    PubMed     Abstract available


    September 2020
  25. ILARDI M, Nolan-Kenney R, Fatterpekar G, Hasanaj L, et al
    Role for OCT in detecting hemi-macular ganglion cell layer thinning in patients with multiple sclerosis and related demyelinating diseases.
    J Neurol Sci. 2020;419:117159.
    PubMed     Abstract available


  26. CHAUDHRY F, Bulka H, Rathnam AS, Said OM, et al
    COVID-19 in multiple sclerosis patients and risk factors for severe infection.
    J Neurol Sci. 2020;418:117147.
    PubMed     Abstract available


  27. JAKIMOVSKI D, Zivadinov R, Dwyer MG, Bergsland N, et al
    High density lipoprotein cholesterol and apolipoprotein A-I are associated with greater cerebral perfusion in multiple sclerosis.
    J Neurol Sci. 2020;418:117120.
    PubMed     Abstract available


    August 2020
  28. GELIBTER S, Orrico M, Moiola L, Dagna L, et al
    Allergy and dimethyl fumarate treatment in a patient with multiple sclerosis.
    J Neurol Sci. 2020;418:117104.
    PubMed    


  29. SHAH Z, Wasay M, Chaudhry BZ, Fredrikson S, et al
    Multiple sclerosis in Pakistan: Current status and future perspective.
    J Neurol Sci. 2020;418:117066.
    PubMed     Abstract available


    July 2020
  30. MINACAPELLI E, Giordano A, Falautano M, Sangalli F, et al
    Risk attitude and personality in people with multiple sclerosis facing the choice of different disease-modifying therapy scenarios.
    J Neurol Sci. 2020;417:117064.
    PubMed     Abstract available


  31. HUGHES AJ, Patel K, Fitzgerald KC, Brown A, et al
    Reliability and validity of the multiple sclerosis resiliency scale (MSRS).
    J Neurol Sci. 2020;418:116983.
    PubMed     Abstract available


  32. LUCA B, Tommaso G, Bavaro DF, Laura M, et al
    Seroconversion and indolent course of COVID-19 in patients with multiple sclerosis treated with fingolimod and teriflunomide.
    J Neurol Sci. 2020;416:117011.
    PubMed    


    June 2020
  33. ABBOUD H, Serra A
    The pressing questions in multiple sclerosis Care in the era of COVID-19.
    J Neurol Sci. 2020;416:117005.
    PubMed    


  34. PROCKL V, Nickel FT, Utz KS, Frohlich K, et al
    Real world application of ocrelizumab in multiple sclerosis: Single-center experience of 128 patients.
    J Neurol Sci. 2020;415:116973.
    PubMed     Abstract available


  35. WELLER D, Lorincz L, Sutter T, Reuter K, et al
    Fampridine-induced changes in walking kinetics are associated with clinical improvements in patients with multiple sclerosis.
    J Neurol Sci. 2020;416:116978.
    PubMed     Abstract available


    May 2020
  36. LAMARGUE D, Koubiyr I, Deloire M, Saubusse A, et al
    Effect of cognitive rehabilitation on neuropsychological and semiecological testing and on daily cognitive functioning in multiple sclerosis: The REACTIV randomized controlled study.
    J Neurol Sci. 2020;415:116929.
    PubMed     Abstract available


  37. KIM H, Lim YM, Kim G, Lee EJ, et al
    Choroid plexus changes on magnetic resonance imaging in multiple sclerosis and neuromyelitis optica spectrum disorder.
    J Neurol Sci. 2020;415:116904.
    PubMed     Abstract available


  38. AHMED SI, Lohana N, Javed G, Bareeqa SB, et al
    Semantic fluency and cognitive function impairment in multiple sclerosis patients.
    J Neurol Sci. 2020;415:116898.
    PubMed    


    April 2020
  39. FALSAFI Z, Tafakhori A, Agah E, Mojarrad M, et al
    Safety and efficacy of memantine for multiple sclerosis-related fatigue: A pilot randomized, double-blind placebo-controlled trial.
    J Neurol Sci. 2020;414:116844.
    PubMed     Abstract available


  40. TSANTES E, Curti E, Collura F, Bazzurri V, et al
    Five- and seven-year prognostic value of new effectiveness measures (NEDA, MEDA and six-month delayed NEDA) in relapsing-remitting multiple sclerosis.
    J Neurol Sci. 2020;414:116827.
    PubMed     Abstract available


    March 2020
  41. CUELLO JP, Martinez Gines ML, Tejeda-Velarde A, Medina Heras S, et al
    Cytokine profile during pregnancy predicts relapses during pregnancy and postpartum in multiple sclerosis.
    J Neurol Sci. 2020;414:116811.
    PubMed     Abstract available


  42. RUSSO C, Cocozza S, Riccio E, Pontillo G, et al
    Prevalence of GLA gene mutations and polymorphisms in patients with multiple sclerosis: A cross-sectional study.
    J Neurol Sci. 2020;412:116782.
    PubMed     Abstract available


  43. SCOTT TF, Bertha N
    The impact of multiple sclerosis relapses on worsening over the long term; insights in the treatment era.
    J Neurol Sci. 2020;413:116773.
    PubMed     Abstract available


  44. FUKUMOTO S, Nakamura Y, Watanabe M, Isobe N, et al
    Risk HLA-DRB1 alleles differentially influence brain and lesion volumes in Japanese patients with multiple sclerosis.
    J Neurol Sci. 2020;413:116768.
    PubMed     Abstract available


    February 2020
  45. OUALLET JC, Radat F, Creange A, Abdellaoui M, et al
    Evaluation of emotional disorders before and during treatment with interferon beta in patients with multiple sclerosis.
    J Neurol Sci. 2020;413:116739.
    PubMed     Abstract available


  46. SOLARO C, Cattaneo D, Basteris A, Carpinella I, et al
    Haptic vs sensorimotor training in the treatment of upper limb dysfunction in multiple sclerosis: A multi-center, randomised controlled trial.
    J Neurol Sci. 2020;412:116743.
    PubMed     Abstract available


  47. RINI AM, Clerici VT, Rinaldi E, Modesto M, et al
    Severe thrombocytopenia during Natalizumab therapy: A case report.
    J Neurol Sci. 2020;409:116587.
    PubMed    


    January 2020
  48. MARTINEZ-LAPISCINA EH, Mahatanan R, Lee CH, Charoenpong P, et al
    Associations of serum 25(OH) vitamin D levels with clinical and radiological outcomes in multiple sclerosis, a systematic review and meta-analysis.
    J Neurol Sci. 2020;411:116668.
    PubMed     Abstract available


    December 2019
  49. GROMISCH ES, Foley FW
    Can semantic fluency be used as an alternative or additional measure in the abbreviated Minimal Assessment of Cognitive Function in Multiple Sclerosis (aMACFIMS)?
    J Neurol Sci. 2019;410:116640.
    PubMed     Abstract available


  50. DE CARVALHO JENNINGS PEREIRA W, Flauzino T, Alfieri DF, Oliveira SR, et al
    Immune-inflammatory, metabolic and hormonal biomarkers are associated with the clinical forms and disability progression in patients with multiple sclerosis: A follow-up study.
    J Neurol Sci. 2019;410:116630.
    PubMed     Abstract available


  51. FUJII T, Yamasaki R, Miyachi Y, Nagata S, et al
    Central nervous system-specific antinuclear antibodies in patients with multiple sclerosis.
    J Neurol Sci. 2019;409:116619.
    PubMed     Abstract available


  52. CRISTIANO E, Rojas JI, Alonso R, Alvez Pinheiro A, et al
    Consensus recommendations on the management of multiple sclerosis patients in Argentina.
    J Neurol Sci. 2019;409:116609.
    PubMed     Abstract available


    November 2019
  53. ZANETTA C, Robotti M, Nozzolillo A, Sangalli F, et al
    Late onset absolute neutropenia associated with ocrelizumab treatment in multiple sclerosis: A case report and review of the literature.
    J Neurol Sci. 2019;409:116603.
    PubMed    


    October 2019
  54. UYGUR M, de Freitas PB, Barone DA
    Rate of force development and relaxation scaling factors are highly sensitive to detect upper extremity motor impairments in multiple sclerosis.
    J Neurol Sci. 2019;408:116500.
    PubMed     Abstract available


  55. CEDERBERG KLJ, Jeng B, Sasaki JE, Braley TJ, et al
    Physical activity, sedentary behavior, and restless legs syndrome in persons with multiple sclerosis.
    J Neurol Sci. 2019;407:116531.
    PubMed     Abstract available


    September 2019
  56. SRIWASTAVA S, Yarraguntla K, Zutshi D, Basha MM, et al
    Relevance of cerebrospinal fluid findings in patients with multiple sclerosis and seizures.
    J Neurol Sci. 2019;406:116482.
    PubMed     Abstract available


  57. O'HERLIHY F, John NA, Li V, Porter B, et al
    Screening for urinary tract colonisation prior to corticosteroid administration in acute multiple sclerosis relapses: Validation of an updated algorithm.
    J Neurol Sci. 2019;407:116456.
    PubMed     Abstract available


  58. HNILICOVA P, Kantorova E, Polacek H, Grendar M, et al
    Altered hypothalamic metabolism in early multiple sclerosis - MR spectroscopy study.
    J Neurol Sci. 2019;407:116458.
    PubMed     Abstract available


    August 2019
  59. SA M, Nunes CC, da Silva AM, Mota P, et al
    JC virus antibodies in Portuguese multiple sclerosis patients: JUSTIFY study results.
    J Neurol Sci. 2019;406:116426.
    PubMed     Abstract available


    June 2019
  60. MINAGAR A, Alexander JS
    Cervical spinal cord atrophy impact on quality of life in MS: A neuroimaging study.
    J Neurol Sci. 2019;401:101-102.
    PubMed    


    February 2019
  61. KAPLAN TB, Bove R, Galetta K, Healy B, et al
    Effect of pregnancy loss on MS disease activity.
    J Neurol Sci. 2019;397:58-60.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: